225 related articles for article (PubMed ID: 34582425)
1. Association of Catecholamine Dose, Lactate, and Shock Duration at Vasopressin Initiation With Mortality in Patients With Septic Shock.
Sacha GL; Lam SW; Wang L; Duggal A; Reddy AJ; Bauer SR
Crit Care Med; 2022 Apr; 50(4):614-623. PubMed ID: 34582425
[TBL] [Abstract][Full Text] [Related]
2. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
3. Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study.
Bauer SR; Sacha GL; Siuba MT; Lam SW; Reddy AJ; Duggal A; Vachharajani V
Crit Care Explor; 2022 Feb; 4(2):e0634. PubMed ID: 35156051
[TBL] [Abstract][Full Text] [Related]
4. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
5. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
6. Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study.
Kulesza S; Gignac L; Colvin CA; Boll S; Giuliano C; Haan B; Allen B; Perez MM; Allen M; Edwin SB
Pharmacotherapy; 2023 Aug; 43(8):787-794. PubMed ID: 37148191
[TBL] [Abstract][Full Text] [Related]
7. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
Jakowenko ND; Murata J; Kopp BJ; Erstad BL
J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
[No Abstract] [Full Text] [Related]
8. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
9. The Therapeutic Role of Vasopressin on Improving Lactate Clearance During and After Vasogenic Shock: Microcirculation, Is It The Black Box?
Barzegar E; Ahmadi A; Mousavi S; Nouri M; Mojtahedzadeh M
Acta Med Iran; 2016 Jan; 54(1):15-23. PubMed ID: 26853286
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Vasopressin Use and Initiation Timing in Septic Shock: A Narrative Review.
Sacha GL; Bauer SR
Chest; 2023 Nov; 164(5):1216-1227. PubMed ID: 37479058
[TBL] [Abstract][Full Text] [Related]
11. EARLY INITIATION OF VASOPRESSIN REDUCES ORGAN FAILURE AND MORTALITY IN SEPTIC SHOCK.
Rydz AC; Elefritz JL; Conroy M; Disney KA; Miller CJ; Porter K; Doepker BA
Shock; 2022 Oct; 58(4):269-274. PubMed ID: 36018257
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin versus norepinephrine infusion in patients with septic shock.
Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
[TBL] [Abstract][Full Text] [Related]
13. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
Anantasit N; Boyd JH; Walley KR; Russell JA
Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
[TBL] [Abstract][Full Text] [Related]
14. Timing of Vasopressin Addition to Norepinephrine and Efficacy Outcomes in Patients With Septic Shock.
Brask AL; Shemanski SM; Barnes TE; Holmes AK
Ann Pharmacother; 2023 May; 57(5):521-526. PubMed ID: 36039490
[TBL] [Abstract][Full Text] [Related]
15. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
[TBL] [Abstract][Full Text] [Related]
16. Effect of Vasopressin Dose on Hemodynamic Response in Obese Patients With Septic Shock: A Retrospective Observational Study.
Dubrawka CA; Betthauser KD; Pope HE; Gibson GA
Ann Pharmacother; 2021 Dec; 55(12):1447-1454. PubMed ID: 33813908
[TBL] [Abstract][Full Text] [Related]
17. Normal-range blood lactate concentration in septic shock is prognostic and predictive.
Wacharasint P; Nakada TA; Boyd JH; Russell JA; Walley KR
Shock; 2012 Jul; 38(1):4-10. PubMed ID: 22552014
[TBL] [Abstract][Full Text] [Related]
18. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
19. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
20. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock.
Levy B; Sadoune LO; Gelot AM; Bollaert PE; Nabet P; Larcan A
Crit Care Med; 2000 Jan; 28(1):114-9. PubMed ID: 10667509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
